Related references
Note: Only part of the references are listed.Assessment of Global Incidence and Mortality of Hospital-treated Sepsis
Carolin Fleischmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
A Selective V-1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock
Xinrong He et al.
CRITICAL CARE MEDICINE (2016)
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Manu Shankar-Hari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical Patients
Michelle H. Scerbo et al.
SURGICAL INFECTIONS (2016)
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
Emma E. Davenport et al.
LANCET RESPIRATORY MEDICINE (2016)
Surviving Sepsis Campaign: Association Between Performance Metrics and Outcomes in a 7.5-Year Study
Mitchell M. Levy et al.
CRITICAL CARE MEDICINE (2015)
Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion: Results From the Surviving Sepsis Campaign Database
Brian Casserly et al.
CRITICAL CARE MEDICINE (2015)
The Efficacy and Safety of Heparin in Patients With Sepsis: A Systematic Review and Metaanalysis
Ryan Zarychanski et al.
CRITICAL CARE MEDICINE (2015)
Posttraumatic Stress Disorder in Critical Illness Survivors: A Metaanalysis
Ann M. Parker et al.
CRITICAL CARE MEDICINE (2015)
Effect of Corticosteroids on Treatmmt Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response A Randomized Clinical Trial
Antoni Torres et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Endothelial barrier dysfunction in septic shock
S. M. Opal et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Neutrophil extracellular traps in patients with sepsis
Masamitsu Hashiba et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
Claudine Angela Blum et al.
LANCET (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set
Timothy E. Sweeney et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
ENHANCED EXPRESSION OF CELL-SPECIFIC SURFACE ANTIGENS ON ENDOTHELIAL MICROPARTICLES IN SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
Hisatake Matsumoto et al.
SHOCK (2015)
Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys
Shihui Sun et al.
CLINICAL INFECTIOUS DISEASES (2015)
Fluid resuscitation in acute medicine: what is the current situation?
J. A. Myburgh
JOURNAL OF INTERNAL MEDICINE (2015)
Sepsis guidelines: Clinical practice implications
Karen D. Lehman et al.
NURSE PRACTITIONER (2015)
A review of sepsis-induced cardiomyopathy
Ryota Sato et al.
JOURNAL OF INTENSIVE CARE (2015)
Glycocalyx and sepsis-induced alterations in vascular permeability
Cosimo Chelazzi et al.
CRITICAL CARE (2015)
Increased 1-Year Healthcare Use in Survivors of Severe Sepsis
Hallie C. Prescott et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Low-Dose Hydrocortisone Therapy Attenuates Septic Shock in Adult Patients but Does Not Reduce 28-Day Mortality: A Meta-Analysis of Randomized Controlled Trials
Changsong Wang et al.
ANESTHESIA AND ANALGESIA (2014)
Erythrocyte-Derived Microvesicles Amplify Systemic Inflammation by Thrombin-Dependent Activation of Complement
Daniel Zecher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression
Z. Zhao et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Rehabilitation Interventions for Postintensive Care Syndrome: A Systematic Review
Juliane Mehlhorn et al.
CRITICAL CARE MEDICINE (2014)
Sepsis: Current Dogma and New Perspectives
Clifford S. Deutschman et al.
IMMUNITY (2014)
Declining Case Fatality Rates for Severe Sepsis Good Data Bring Good News With Ambiguous Implications
Theodore J. Iwashyna et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
Vincent Liu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012
Kirsi-Maija Kaukonen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Persistent inflammation- immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit
Dong Hu et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2014)
Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma
Erin L. Vanzant et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2014)
An extracorporeal blood-cleansing device for sepsis therapy
Joo H. Kang et al.
NATURE MEDICINE (2014)
Regulatory Mandates for Sepsis Care - Reasons for Caution
Chanu Rhee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Parallels between Cancer and Infectious Disease
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Randomized Trial of Protocol-Based Care for Early Septic Shock
Donald M. Yealy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Reactivation of Multiple Viruses in Patients with Sepsis
Andrew H. Walton et al.
PLOS ONE (2014)
Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T- cells to Be Suppressed In Vivo
Nicholas M. Durham et al.
PLOS ONE (2014)
Long Term Health-Related Quality of Life in Survivors of Sepsis in South West Wales: An Epidemiological Study
Ceri E. Battle et al.
PLOS ONE (2014)
PERSISTENT LYMPHOPENIA AFTER DIAGNOSIS OF SEPSIS PREDICTS MORTALITY
Anne M. Drewry et al.
SHOCK (2014)
Special issue: Sepsis The new normal: immunomodulatory agents against sepsis immune suppression
Noe Ile A. Hutchins et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Special issue: Sepsis Gene expression profiling in sepsis: timing, tissue, and translational considerations
David M. Maslove et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Special issue: Sepsis Why have clinical trials in sepsis failed?
John C. Marshall
TRENDS IN MOLECULAR MEDICINE (2014)
Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials
Zhengdong Kong et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2013)
Recombinant Human Activated Protein C for Adults with Septic Shock A Randomized Controlled Trial
Djillali Annane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection
Shihui Sun et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Severe Sepsis Cohorts Derived From Claims-Based Strategies Appear to be Biased Toward a More Severely Ill Patient Population
Stacey-Ann Whittaker et al.
CRITICAL CARE MEDICINE (2013)
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States
David F. Gaieski et al.
CRITICAL CARE MEDICINE (2013)
Innate Immune Functions of Immature Neutrophils in Patients With Sepsis and Severe Systemic Inflammatory Response Syndrome
Genevieve Drifte et al.
CRITICAL CARE MEDICINE (2013)
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation
Jean-Louis Vincent et al.
CRITICAL CARE MEDICINE (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial
Steven M. Opal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
Erin E. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
Xiaomei Yang et al.
JOURNAL OF IMMUNOLOGY (2013)
Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors
Alexander Semmler et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis
Laura E. White et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2013)
Sepsis definitions: time for change
Jean-Louis Vincent et al.
LANCET (2013)
Measuring the Global Burden of Disease
Christopher J. L. Murray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Severe Sepsis and Septic Shock REPLY
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung Injury
Cristiana C. Garcia et al.
PLOS ONE (2013)
Sepsis and Thrombosis
Marcel Levi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS
Samir M. Parikh
VIRULENCE (2013)
Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010
Duncan McPherson et al.
BMJ OPEN (2013)
Why Activated Protein C Was Not Successful in Severe Sepsis and Septic Shock: Are We Still Tilting at Windmills?
Peggy S. Lai et al.
CURRENT INFECTIOUS DISEASE REPORTS (2013)
Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis
Katherine C. Chang et al.
CRITICAL CARE (2013)
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial
Jianfeng Wu et al.
CRITICAL CARE (2013)
Severe Sepsis and Septic Shock
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Reversal of Immunoparalysis in Humans In Vivo A Double-Blind, Placebo-controlled, Randomized Pilot Study
Jenneke Leentjens et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
Y. Levy et al.
CLINICAL INFECTIOUS DISEASES (2012)
Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?
Sarah Heenen et al.
CRITICAL CARE MEDICINE (2012)
Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis
Daniel De Backer et al.
CRITICAL CARE MEDICINE (2012)
PAMPs and DAMPs: signal 0s that spur autophagy and immunity
Daolin Tang et al.
IMMUNOLOGICAL REVIEWS (2012)
Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients
Konrad Reinhart et al.
INTENSIVE CARE MEDICINE (2012)
What is the best method for estimating the burden of severe sepsis in the United States?
Tara Lagu et al.
JOURNAL OF CRITICAL CARE (2012)
IL-7 Restores Lymphocyte Functions in Septic Patients
Fabienne Venet et al.
JOURNAL OF IMMUNOLOGY (2012)
Interleukin-7 Ameliorates Immune Dysfunction and Improves Survival in a 2-Hit Model of Fungal Sepsis
Jacqueline Unsinger et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care
Lori F. Gentile et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome
Peter E. Morris et al.
BMC PULMONARY MEDICINE (2012)
Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality
Issrah Jawad et al.
Journal of Global Health (2012)
Causes of pediatric mortality and case-fatality rates in eight Medecins Sans Frontisres-supported hospitals in Africa
W. van den Boogaard et al.
PUBLIC HEALTH ACTION (2012)
Oxidative stress and mitochondrial dysfunction in sepsis
H. F. Galley
BRITISH JOURNAL OF ANAESTHESIA (2011)
Guidelines for the Prevention of Intravascular Catheter-related Infections
Naomi P. O'Grady et al.
CLINICAL INFECTIOUS DISEASES (2011)
Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality
Jean-Ralph Zahar et al.
CRITICAL CARE MEDICINE (2011)
Genetic predisposition to respiratory infection and sepsis
Li Ping Chung et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death
Ping Qiu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma
Alex G. Cuenca et al.
MOLECULAR MEDICINE (2011)
The implications and management of septic acute kidney injury
Zaccaria Ricci et al.
NATURE REVIEWS NEPHROLOGY (2011)
DOSE-DEPENDENT EFFECT OF ANTI-CTLA-4 ON SURVIVAL IN SEPSIS
Shigeaki Inoue et al.
SHOCK (2011)
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis
Allison Sutherland et al.
CRITICAL CARE (2011)
The late phase of sepsis is characterized by an increased microbiological burden and death rate
Gordon P. Otto et al.
CRITICAL CARE (2011)
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
Scott T. Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Marital Status and the Epidemiology and Outcomes of Sepsis
Christopher W. Seymour et al.
CHEST (2010)
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2010)
Inflammation and coagulation
Marcel Levi et al.
CRITICAL CARE MEDICINE (2010)
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Interleukin-7 (IL-7) Treatment Accelerates Neutrophil Recruitment through γδ T-Cell IL-17 Production in a Murine Model of Sepsis
Kevin R. Kasten et al.
INFECTION AND IMMUNITY (2010)
Lactate Clearance vs Central Venous Oxygen Saturation as Goals of Early Sepsis Therapy A Randomized Clinical Trial
Alan E. Jones et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis
Shigeaki Inoue et al.
JOURNAL OF IMMUNOLOGY (2010)
The Harmful Role of C5a on Innate Immunity in Sepsis
Peter A. Ward
JOURNAL OF INNATE IMMUNITY (2010)
Comparison of Dopamine and Norepinephrine in the Treatment of Shock.
Daniel De Backer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza
Nyall R. London et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy
B. N. Mayanja et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Long-term physical outcome in patients with septic shock
J. B. Poulsen et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2009)
Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
Christian Meisel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with Sepsis
Christian Torgersen et al.
ANESTHESIA AND ANALGESIA (2009)
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
Anand Kumar et al.
CHEST (2009)
Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2009)
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults A Systematic Review
Djillali Annane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
Creg J. Workman et al.
JOURNAL OF IMMUNOLOGY (2009)
Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study
Eizo Watanabe et al.
LABORATORY INVESTIGATION (2009)
Surviving sepsis in low-income and middle-income countries: new directions for care and research
Joseph U. Becker et al.
LANCET INFECTIOUS DISEASES (2009)
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
Xin Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Interdependence of hypoxic and innate immune responses
Victor Nizet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The impact of critical illness on perceived health-related quality of life during ICU treatment, hospital stay, and after hospital discharge - A long-term follow-up study
Jose G. M. Hofhuis et al.
CHEST (2008)
Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria
Katherhie E. Kollef et al.
CHEST (2008)
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain
Ricard Ferrer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Functional roles for C5a receptors in sepsis
Daniel Rittirsch et al.
NATURE MEDICINE (2008)
Vasopressin versus norepinephrine infusion in patients with septic shock
James A. Russell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
IMMATURE CIRCULATING NEUTROPHILS IN SEPSIS HAVE IMPAIRED PHAGOCYTOSIS AND CALCIUM SIGNALING
Ravi Taneja et al.
SHOCK (2008)
Improving Care of the Sepsis Patient
Marc T. Zubrow et al.
JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY (2008)
Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers
Kamal U. Saikh et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox
Anna Rubartelli et al.
TRENDS IN IMMUNOLOGY (2007)
MyD88-dependent expansion of an immature GR-1+ CD11b+ population induces T cell suppression and Th2 polarization in sepsis
Matthew J. Delano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003
Viktor Y. Dombrovskiy et al.
CRITICAL CARE MEDICINE (2007)
Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients
Anne Kaarlola et al.
CRITICAL CARE MEDICINE (2006)
Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis
Steven J. Schwulst et al.
JOURNAL OF IMMUNOLOGY (2006)
TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo
Richard S. Hotchkiss et al.
JOURNAL OF IMMUNOLOGY (2006)
An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study
CL Sprung et al.
INTENSIVE CARE MEDICINE (2006)
Sepsis in European intensive care units: Results of the SOAP study
JL Vincent et al.
CRITICAL CARE MEDICINE (2006)
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome
Andrew F. Shorr et al.
CRITICAL CARE (2006)
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis
BG Zeiher et al.
CRITICAL CARE MEDICINE (2005)
Quality of life in adult survivors of critical illness: A systematic review of the literature
DW Dowdy et al.
INTENSIVE CARE MEDICINE (2005)
Epidemiology of sepsis in Victoria, Australia
V Sundararajan et al.
CRITICAL CARE MEDICINE (2005)
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
RP Dellinger et al.
CRITICAL CARE MEDICINE (2004)
Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis
K Reinhart et al.
CRITICAL CARE MEDICINE (2004)
The symptom burden of chronic critical illness
JE Nelson et al.
CRITICAL CARE MEDICINE (2004)
Akt decreases lymphocyte apoptosis and improves survival in sepsis
U Bommhardt et al.
JOURNAL OF IMMUNOLOGY (2004)
Administration of the nitric oxide synthase inhibitor N-G-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)
J Bakker et al.
CRITICAL CARE MEDICINE (2004)
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care
MD Williams et al.
CRITICAL CARE (2004)
Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma
S Flohé et al.
CRITICAL CARE MEDICINE (2003)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
E Abraham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and-10 levels in critically ill patients with sepsis
M Hynninen et al.
SHOCK (2003)
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
WC Aird
BLOOD (2003)
Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia
CM Coopersmith et al.
SHOCK (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Science review: Role of coagulation protease cascades in sepsis
M Riewald et al.
CRITICAL CARE (2003)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis
RK Root et al.
CRITICAL CARE MEDICINE (2003)
Mechanisms involved in interleukin-15-induced suppression of human neutrophil apoptosis:: role of the anti-apoptotic Mcl-1 protein and several kinases including Janus kinase-2, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases-1/2
M Pelletier et al.
FEBS LETTERS (2002)
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
E Rivers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
BL Warren et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients
E Abraham et al.
CRITICAL CARE MEDICINE (2001)
Bacteraemia and mortality among adult medical admissions in Malawi - Predominance of non-typhi Salmonellae and Streptococcus pneumoniae
MA Gordon et al.
JOURNAL OF INFECTION (2001)
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
RS Hotchkiss et al.
NATURE IMMUNOLOGY (2000)
Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: A prospective, multicenter, double-blind, randomized phase II trial
M Poeze et al.
SHOCK (2000)
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis:: a randomised trial
M Levin et al.
LANCET (2000)
E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial
DC Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis
Y Suputtamongkol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
